| Literature DB >> 27214150 |
Mingfeng Yu1, Gayathri Nagalingam2, Samantha Ellis2, Elena Martinez3, Vitali Sintchenko3, Malcolm Spain1, Peter J Rutledge1, Matthew H Todd1, James A Triccas2.
Abstract
Tuberculosis (TB) accounted for 1.5 million deaths in 2014, and new classes of anti-TB drugs are required. We report a class of functionalized 1,8-disubstituted cyclam derivatives that display low micromolar activity against pathogenic mycobacteria. These compounds inhibit intracellular growth of Mycobacterium tuberculosis, are nontoxic to human cell lines, and are active against multidrug-resistant M. tuberculosis strains, indicating a distinct mode of action. These compounds warrant further appraisal as novel agents to control TB in humans.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27214150 DOI: 10.1021/acs.jmedchem.6b00432
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446